Celecoxib (Celebrex) Versus Placebo in Men With Recurrent Prostate Cancer

NCT00136487 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

85

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Celecoxib

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]